Effects of SGLT-2 inhibitor on myocardial fibrosis and left ventricular reverse remodeling
Guardado en:
Autores principales: | Dipak Katare, Arun Mohanty, Vyom Mori, Rajaram Mantri |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dd672189bc6347258a53c4ef7a7a242a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
por: Zeping Qiu, et al.
Publicado: (2021) -
Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction
por: Michał Węgiel, et al.
Publicado: (2021) -
Factors associated with left ventricular reverse remodelling after percutaneous coronary intervention in patients with left ventricular systolic dysfunction
por: Yusuke Adachi, et al.
Publicado: (2021) -
Circulating microRNAs as biomarkers for myocardial fibrosis in patients with left ventricular non-compaction cardiomyopathy
por: Zofia M. Szemraj-Rogucka, et al.
Publicado: (2019) -
Left ventricular remodeling patterns in children with metabolic syndrome
por: Veronica ESANU, et al.
Publicado: (2020)